Klibanov, Olga M <br/><br/>
Ombitasvir/paritaprevir/ritonavir and dasabuvir tablets for hepatitis C virus genotype 1 infection.  [electronic resource] 

 -  The Annals of pharmacotherapy  May 2015 
 - 566-81 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1542-6270 
<br/><br/><label>Standard No.: </label>10.1177/1060028015570729  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>2-Naphthylamine<br/>Anilides--therapeutic use<br/>Antiviral Agents--therapeutic use<br/>Carbamates--therapeutic use<br/>Clinical Trials, Phase I as Topic<br/>Clinical Trials, Phase II as Topic<br/>Clinical Trials, Phase III as Topic<br/>Cyclopropanes<br/>Drug Combinations<br/>Drug Resistance, Viral<br/>Drug Therapy, Combination<br/>Genotype<br/>Hepacivirus--genetics<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Lactams, Macrocyclic<br/>Liver Cirrhosis--drug therapy<br/>Macrocyclic Compounds--therapeutic use<br/>Proline--analogs & derivatives<br/>Ribavirin--therapeutic use<br/>Ritonavir--therapeutic use<br/>Sulfonamides--therapeutic use<br/>Tablets<br/>Uracil--analogs & derivatives<br/>Valine